Day: July 14, 2025

SOMERSET, N.J., July 14, 2025 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced the appointment of two new members to its Board of Directors (“Board”). Effective July 12, 2025, Kevin M. Moriarty and Rebecca K. Corbin Loree have joined the company as independent directors. “We’re excited to welcome Kevin and Rebecca to our Board of Directors. Their deep financial and capital markets expertise will help strengthen our strategic oversight and support our efforts to drive long-term value for CompoSecure and our shareholders,” said David Cote, Executive Chairman of CompoSecure’s Board. Ms. Corbin Loree is Chief Executive Officer of Corbin Advisors, LLC, a leading strategic investor relations and communications advisory firm, which she founded...

WATERTOWN, Mass., July 14, 2025 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the appointment of Nadim Ahmed to its Board of Directors. Mr. Ahmed is currently the President and Chief Executive Officer of Cullinan Therapeutics. “I am excited to welcome Nadim to Disc’s Board of Directors at such a pivotal moment for the company,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc. “His track record of successful drug launches and deep expertise in hematological diseases will be invaluable as we advance bitopertin towards commercialization in EPP and continue development of the rest of our hematology pipeline.” “With...

HOUSTON, July 14, 2025 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional extension to regain compliance with Nasdaq Listing Rule 5550(b)(1) (Equity Standard) by late July 2025. As previously disclosed, Salarius must also regain compliance with Nasdaq Listing Rule 5550(a)(2) (Minimum Bid Price Requirement) by early August 2025. On April 23, 2025, Salarius was notified by Nasdaq that it was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the closing bid price of Salarius’ common stock for the prior 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share. On March 26, 2025, Nasdaq notified the Company that it no longer...

July 14, 2025 Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced the filing of a Clinical Trial Application (CTA) with the European Medicines Agency (EMA) for its Serenta trial in patients with familial adenomatous polyposis (FAP), a mostly inherited disease that, if left untreated, almost always leads to colorectal cancer. The only current treatment option is sequential resection of much of the gastrointestinal tract. A CTA is the formal regulatory submission required to obtain approval to begin a clinical trial in Europe and is similar to the Investigational...

Seasoned engineering executive brings 23 years of global experience; will lead Hyderabad operations, support Malaysia Fab2 ramp, and drive strategic growth across India FREMONT, Calif., July 14, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (Nasdaq: ENVX) (“Enovix”), a leader in advanced silicon battery technology, today announced the appointment of Srikanth Kethu as Head of Enovix India, effective today. In this key leadership role, Mr. Kethu will oversee the company’s Hyderabad R&D center and play a strategic role in supporting the ramp-up of Enovix’s high-volume manufacturing facility in Malaysia, while driving the broader expansion of Enovix’s footprint in India. Mr. Kethu brings more than two decades of experience leading high-performance engineering teams and scaling offshore operations for global automotive and industrial...

NORWOOD, Mass., July 14, 2025 (GLOBE NEWSWIRE) — MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD) today announced a licensing agreement with The Stoned Moose, LLC (“The Stoned Moose”), a vertically integrated cannabis operator in Maine. This partnership will significantly expand the distribution of the Company’s top-selling Betty’s Eddies™ full-spectrum fruit chews in the $455 million Maine cannabis marketplace. Terms of the deal were not disclosed. Betty’s Eddies has been available exclusively to adult-use cannabis consumers in Maine since 2022 through a former licensing partner. The new agreement with The Stoned Moose, which owns a license that allows for both adult-use and medical cannabis distribution, will enable the state’s medical cannabis patients to purchase the brand as well. Medical cannabis sales...

FORT COLLINS, Colo., July 14, 2025 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ: WWD) announced today that it expects to report its fiscal 2025 third quarter financial results at approximately 4:00 p.m. ET on Monday, July 28, 2025. A news release will be issued at that time, and a conference call will be held at 5:00 p.m. ET. During the conference call, the company will provide an overview of its business and financial performance. You are invited to listen to the call live via the company’s website, www.woodward.com. The call and presentation will be available on the website by selecting “Investors / Events and Presentations” from the menu and will remain accessible on the company’s website for one year. You may also listen to the call by dialing +1 (800) 715-9871 (U.S. / Canada) or +1 (646) 307-1963 (outside U.S.). The Conference...